Bill Text: TX HB3707 | 2019-2020 | 86th Legislature | Introduced


Bill Title: Relating to value-based arrangements for prescription drugs in Medicaid.

Spectrum: Partisan Bill (Republican 1-0)

Status: (Introduced) 2019-04-16 - Left pending in committee [HB3707 Detail]

Download: Texas-2019-HB3707-Introduced.html
 
 
  By: Parker H.B. No. 3707
 
 
 
A BILL TO BE ENTITLED
 
AN ACT
  relating to value-based arrangements for prescription drugs in
  Medicaid.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  Section 531, Government Code, is amended by
  adding Section 531.0701 to read as follows:
         
  Sec. 531.0701.  VALUE-BASED ARRANGEMENTS. Subject to
  531.071, the commission may enter into a written agreement with a
  manufacturer of prescription drugs as defined by 42 U.S.C. Section
  1396r-8(k)(5) and its subsequent amendments, including a
  subsidiary or affiliate of a manufacturer, based on outcomes data,
  or other metrics agreed to in writing by the state and a
  pharmaceutical manufacturer. Such agreements may include but not
  be limited to rebates, discounts, price reductions, contributions,
  risk sharing, reimbursements, deferral of payments (e.g.
  installment payments), guarantees, patient care, shared savings
  payments, withholds, or bonuses or anything of value.
         SECTION 2.  The Health and Human Services Commission shall
  amend contracts with managed care plans to ensure those contracts
  comply with Section 531.0701, Government Code, as added by this
  Act.
         SECTION 3.  This Act takes effect September 1, 2019.
feedback